Liposomal Formulations to Improve Antioxidant Power of Myrtle Berry Extract for Potential Skin Application

dc.contributor.authorLuca, Maria De
dc.contributor.authorLucchesi, Daniela
dc.contributor.authorTuberoso, Carlo Ignazio Giovanni
dc.contributor.authorFernández Busquets, Xavier
dc.contributor.authorVassallo, Antonio
dc.contributor.authorMartelli, Giuseppe
dc.contributor.authorFadda, Anna Maria
dc.contributor.authorPucci, Laura
dc.contributor.authorCaddeo, Carla
dc.date.accessioned2022-05-10T08:02:08Z
dc.date.available2022-05-10T08:02:08Z
dc.date.issued2022-04-24
dc.date.updated2022-05-10T06:02:39Z
dc.description.abstractMany substances in plant extracts are known for their biological activities. These substances act in different ways, exerting overall protective effects against many diseases, especially skin disorders. However, plant extracts’ health benefits are often limited by low bioavailability. To overcome these limitations, drug delivery systems can be employed. In this study, we evaluated the antioxidant power of an ethanolic extract from Myrtus communis L. (myrtle) berries through colorimetric tests (DPPH and FRAP). The antioxidant activity was also verified by using fibroblast cell culture through cellular Reactive Oxygen Species (ROS) levels measurements. Moreover, the myrtle extract was formulated in phospholipid vesicles to improve its bioavailability and applicability. Myrtle liposomes were characterized by size, surface charge, storage stability, and entrapment efficiency; visualized by using cryo-TEM images; and assayed for cytocompatibility and anti-ROS activity. Our results suggest that myrtle liposomes were cytocompatible and improved the extract’s antioxidant power in fibroblasts, suggesting a potential skin application for these formulations and confirming that nanotechnologies could be a valid tool to enhance plant extracts’ potentialities.
dc.format.extent12 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idimarina6550176
dc.identifier.issn1999-4923
dc.identifier.urihttps://hdl.handle.net/2445/185447
dc.language.isoeng
dc.publisherMDPI AG
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/pharmaceutics14050910
dc.relation.ispartofPharmaceutics, 2022, vol.14, num. 5, p. 910
dc.relation.urihttps://doi.org/10.3390/pharmaceutics14050910
dc.rightscc by (c) Luca, Maria De et al., 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut de Bioenginyeria de Catalunya (IBEC))
dc.subject.classificationLiposomes
dc.subject.classificationAntioxidants
dc.subject.classificationMalalties de la pell
dc.subject.classificationCompostos bioactius vegetals
dc.subject.otherLiposomes
dc.subject.otherAntioxidants
dc.subject.otherSkin diseases
dc.subject.otherPlant bioactive compounds
dc.titleLiposomal Formulations to Improve Antioxidant Power of Myrtle Berry Extract for Potential Skin Application
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
2022_Pharmaceutics_Liposomal_FernandezX.pdf
Mida:
2.59 MB
Format:
Adobe Portable Document Format